Motilal Oswal Nasdaq 100 FOF - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Motilal Oswal Nasdaq 100 FOF - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Motilal Oswal Nasdaq 100 FOF - Direct (G)

59.71%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

-

-

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

500

8267.17

0.18

67.2022

November 9, 2018

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

23.36 %

36.42 %

59.71 %

14.01 %

19.35 %

7.4 %

Ashish Agarwal

PGDBM in Finance from Institute of Management Technology, Ghaziabad and Bachelor of Commerce. from University of Lucknow.

Past Experience  Motilal Oswal Asset Management Company Limited from 2016 till date  Citigroup Global Markets Limited from 2010 to 201.

Swapnil Mayekar

M.Com from Mumbai University and Advanced Diploma in Business Administration from Welingkar, Mumbai

Prior to joining Motilal Oswal AMC he worked with Business Standard Limited from Aug 2005 to Feb 2010.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right